Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients
Phase of Trial: Phase I
Latest Information Update: 21 Oct 2011
At a glance
- Drugs Sarilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 21 Oct 2011 Actual patient no is 32 as reported by ClinicalTrials.gov.
- 21 Oct 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 21 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.